Riskpilot← Back to searchSign inGet full accessSIVERTSEN HELSE AS
ASActiveOrg 997845684Kyrre Grepps Gate 18, 0479 OsloGeneral medical practice activities · NACE 8621Est. 20122 employees
Revenue 2025
NOK 3,3M
+12% vs 2024
EBITDA margin
49.3%
+13% vs 2024
Equity ratio
91.3%
Financial strength
Net profit 2025
NOK 1,4M
-75% vs 2024
| Revenue | NOK 3,3M | +12% |
| EBITDA | NOK 1,6M | +13% |
| Net profit | NOK 1,4M | -75% |
| Total assets | NOK 5,7M | -15% |
| Equity | NOK 5,2M | -17% |
| Employees | 2 | — |
Legal name
SIVERTSEN HELSE AS
Org number
997845684
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
17. januar 2012
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Allmenn legetjeneste, samt rådgivning og ledelse i næringslivet, utleie av arbeidskraft, musikalsk utøvelse, produksjon og distribusjon og alt hva hermed er i forbindelse, samt investeringer i eiendom og deltakelse i andre foretak.
Address
Kyrre Grepps Gate 18, 0479 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 680 | 2 866 | 1 814 | 2 966 | 3 316 |
| Staff expenses | −151 | −161 | −211 | −335 | −415 |
| EBITDA | 886 | 1 338 | 311 | 1 447 | 1 634 |
| Depreciation & amort. | −85 | −87 | −12 | −10 | −10 |
| EBIT | 801 | 1 251 | 299 | 1 437 | 1 624 |
| Net financials | 788 | 577 | 1 024 | 4 719 | 173 |
| Profit before tax | 1 588 | 1 828 | 1 322 | 6 156 | 1 796 |
| Tax | 190 | 296 | 86 | 331 | 367 |
| Net profit | 1 398 | 1 532 | 1 236 | 5 825 | 1 429 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 967 | 5 676 | 6 710 | 6 711 | 5 721 |
| Equity | 3 701 | 5 233 | 6 470 | 6 295 | 5 224 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 266 | 442 | 241 | 416 | 498 |
| Total debt | 266 | 442 | 241 | 416 | 498 |
EBITDA margin
49.3%
This company
15.8%
Market median
+212% vs market
20212025
Equity ratio
91.3%
This company
38.2%
Market median
+139% vs market
20212025
Return on equity
27.4%
This company
18.4%
Market median
+49% vs market
20212025
Net profit margin
43.1%
This company
8.1%
Market median
+432% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ØS Chief Executive Officer | Chief Executive Officer | 2012 |
IC Deputy Member | Deputy Member | 2012 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SIVERTSEN HELSE AS (this company)
MEDU NORGE ASBoard members of SIVERTSEN HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Øyvind Stople Sivertsen | Chief Executive Officer | 0 companies |
| Ingelinn Chemosop Strømme Sivertsen | Deputy Member | 0 companies |